Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

Clinical trial NCT07168226 · RECRUITING

Trial details

NCT number: NCT07168226
Sponsor: MetaFines
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cachexia; Cancer

Start date: 2026-05-08
Primary completion: 2028-04-30
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.